HaCaT Cells as a Reliable In Vitro Differentiation Model to Dissect the Inflammatory/Repair Response of Human Keratinocytes.
Colombo I, Sangiovanni E, Maggio R, Mattozzi C, Zava S, Corbett Y, Fumagalli M, Carlino C, Corsetto PA, Scaccabarozzi D, Calvieri S, Gismondi A, Taramelli D, Dell'Agli M. · 2017
Read HaCaT Cells as a Reliable In Vitro Differentiation Model to Dissect the Inflammatory/Repair Response of Human Keratinocytes. by Colombo I, Sangiovanni E, Maggio R, Mattozzi C, Zava S, Corbett Y, Fumagalli M, Carlino C, Corsetto PA, Scaccabarozzi D, Calvieri S, Gismondi A, Taramelli D, Dell'Agli M. (2017) in the Tower of Babel, a free online library of public-domain works preserved in clean, searchable text. No sign-up. The full text is served as a plain-text file at a predictable URL, where text is present: https://antarctic-labs.com/tower-of-babel/europmc-pmc5748104.txt.
Introduction
Colombo and co-authors test HaCaT cells as a stand-in for normal human skin cells. HaCaT is a long lived keratinocyte line that can mature in culture. Fresh donor cells vary a lot and live briefly, which muddies results. The team checked how culture settings change the line's output of inflammatory signals.
Calcium level, cell density, and serum each shifted mediator release, they report. Cells kept at low calcium and 80% coverage acted much like normal keratinocytes. That match held for cytokine and chemokine output. The authors back HaCaT as a model for testing anti-inflammatory skin treatments.
Catalog record
| CREATOR | Colombo I, Sangiovanni E, Maggio R, Mattozzi C, Zava S, Corbett Y, Fumagalli M, Carlino C, Corsetto PA, Scaccabarozzi D, Calvieri S, Gismondi A, Taramelli D, Dell'Agli M. |
|---|---|
| YEAR | 2017 |
| COLLECTION | PAPERS |
| FORMAT | TXT |
| FILE SIZE | 48 KB |
| LICENSE | CC BY 4.0 |
| RIGHTS | CC BY |
| SOURCE | Europe PMC |
Browse the full library · About the Tower of Babel
Full text
The opening of the work, from the library's hosted text:
HaCaT Cells as a Reliable In Vitro Differentiation Model to Dissect the Inflammatory/Repair Response of Human Keratinocytes By Irma Colombo, Enrico Sangiovanni, Roberta Maggio, Carlo Mattozzi, Stefania Zava, Yolanda Corbett, Marco Fumagalli, Claudia Carlino, Paola Antonia Corsetto, Diletta Scaccabarozzi, Stefano Calvieri, Angela Gismondi Published in: Mediators of Inflammation DOI: 10.1155/2017/7435621 ABSTRACT Abstract Cultured primary human keratinocytes are frequently employed for studies of immunological and inflammatory responses; however, interpretation of experimental data may be complicated by donor to donor variability, the relatively short culture lifetime, and variations between passages. To standardize the in vitro studies on keratinocytes, we investigated the use of HaCaT cells, a long-lived, spontaneously immortalized human keratinocyte line which is able to differentiate in vitro, as a suitable model to follow the release of inflammatory and repair mediators in response to TNFα or IL-1β. Different treatment conditions (presence or absence of serum) and differentiation stimuli (increase in cell density as a function of time in culture and elevation of extracellular calcium) were considered. ELISA and Multiplex measurement technologies were used to monitor the production of cytokines and chemokines. Taken together, the results highlight that Ca2+ concentration in the medium, cell density, and presence of serum influences at different levels the release of proinflammatory mediators by HaCaT cells. Moreover, HaCaT cells maintained in low Ca2+ medium and 80% confluent are similar to normal keratinocytes in terms of cytokine production suggesting that HaCaT cells may be a useful model to investigate anti-inflammatory interventions/therapies on skin diseases. 1. INTRODUCTION The skin is a continuously self-renewing organ that dynamically manages the outside-inside-outside relationships of the human body and actively participates in the host defenses [1]. Keratinocytes (KCs) represent 95% of the epidermal cells. Primarily, they play the structural and barrier function of the epidermis, but their role in the initiation and perpetuation of skin inflammatory and immunological responses, and wound repair, is also well recognized [2]. Under homeostatic conditions, KCs differentiate and mature from proliferating nucleated basal cells to the highly differentiated, nucleus-free corneocytes. Each stage of differentiation is characterized by the expression of structural proteins, such as keratins (K) and lipids [3, 4]. For example, the expression of K5 and K14 is restricted to the basal layer, whereas K1 and K10 appear on more differentiated suprabasal cells [4], and involucrin, loricrin, and keratolinin, in the cells of the uppermost spinous layer [1]. Terminal differentiation is driven by various cytokines and growth factors, and it is typically associated with the formation of the peripheral envelopes, rich in proteins and lipids [3, 4]. The calcium (Ca2+) gradient in the epidermis, increasing from the basal to the granular layer, represents one of the most important triggers of KC differentiation [4]. Resting KCs produce epidermal growth factor receptor (EGFR) ligands and vascular endothelial growth factor (VEGF), but when activated by bacterial products or by direct damage by UV light or chemicals, the expression of cytokines and chemokines changes [5, 6]. In skin diseases, such as psoriasis [7] or atopic dermatitis [8], the cytokine/chemokine network is even more complex and autocrine/paracrine loops are described [2]. Cultured human KCs are frequently employed for studies of KC functions in chronic inflammatory skin diseases [9, 10]. Primary KCs cultured in vitro at low Ca2+ concentration retain a basal phenotype, and they differentiate upon addition of Ca2+ > 0.1 mM [11, 12]. However, their use for routine monitoring of the inflammatory response of the inflamed skin presents major drawbacks. Firstly, fresh human KCs require supplementary growth factors to survive and proliferate in vitro; secondly, once induced to differentiate, they rapidly die and do not allow long-term investigation of the differentiation signals [13]. Moreover, donor-to-donor variability in growth characteristics and in vitro responses, different plating efficiencies, the short lifetime in culture, and the changes in proliferation and differentiation characteristics with increasing number of passages, complicates the interpretation of experimental data. To minimize these problems, the spontaneously immortalized human KC cell line HaCaT from adult skin has been proposed as a model for the study of KC functions. HaCaT is a nontumorigenic monoclonal cell line, adapted to long-term growth without feed-layer or supplemented growth factors [13, 14]; it exhibits normal morphogenesis and expresses all the major surface markers and functional activities of isolated KC [14]; upon stimulation, HaCaT cells differentiate and express specific markers of differentiation, such as K14, K10, and involucrin. They can also form stratified epidermal structure [15], but they can revert, back and forth, between a differentiated and a basal state upon changes in Ca2+ concentration in the medium [16]; they retain the capacity to reconstitute a well-structured epidermis after transplantation in vivo [17]. The aim of the present study was to investigate and optimize the best conditions to use HaCaT cells as a reliable in vitro model to evaluate, at different stages of differentiation, the production of proinflammatory mediators, chosen among those mostly involved in skin inflammation and angiogenesis. 2. MATERIALS AND METHODS 2.1. Cell Culture HaCaT cells, spontaneously immortalized human keratinocyte line [15], were kindly provided by Cell Line Service GmbH (Eppelheim, Germany) and cultured in 5% CO2 at 37°C in regular Dulbecco's Modified Eagle's Medium (DMEM) (Euroclone S.P.A., Milan, Italy) containing 1.8 mM Ca2+, or with DMEM (Gibco, Life Technologies, Carlsbad, CA, USA) at low concentration of Ca2+ (0.07 mM). Both media were supplemented with 10% heat-inactivated fetal bovine serum, glutamine (2 mM), penicillin (100 U⁄ml) (Euroclone), and streptomycin (100 mg⁄ml) (Euroclone). For all experiments, cells were seeded at a density of 5.7 × 103 cells⁄cm2 and cultured with DMEM at high or low Ca2+concentration for 6 or 14 days. The samples were labeled as follows: A6, cells cultured for 6 days with low Ca2+ concentration (0.07 mM) and tested when 80% confluent; A14, cells cultured for 14 days with low Ca2+ concentration (0.07 mM) and tested when overconfluent; C6, cells cultured for 6 days with high Ca2+ concentration (1.8 mM) and tested when 80% confluent; and C14, cells cultured for 14 days with high Ca2+ concentration (1.8 mM) and tested when overconfluent. The medium was changed every 2 days. A flow chart with details of the experimental protocol is reported in Figure 1. [Figure: A flow chart with details of the experimental protocol performed on HaCaT cells.] 2.2. Isolation of Human Keratinocytes from Skin Biopsies Primary KCs were isolated from nonlesional skin biopsies obtained from adult psoriatic patients not receiving either topical or systemic therapies for at least 6 months, or at the time of sample collection. To separate the epidermal layer from the basement membrane, the 0.4 mm punch biopsy was treated with dispase (Gibco BRL, Gaithersburg, MD, USA). After 18 h at 4°C, the epidermal sheet was separated mechanically and dissociated with TrypLE (Gibco BRL, Gaithersburg, MD, USA) for 20 min at 37°C. The obtained primary cells were then plated on 6-well tissue culture plates (Costar), precoated with coating matrix (type I collagen, Gibco BRL), cultured using a specific keratinocyte-serum-free media at low Ca2+ concentration (<0.07 mM), and supplemented with human keratinocyte growth factors (Gibco BRL). When the monolayer reached 60%–70% confluence, cells were split by trypsinization. For all the experiments, keratinocyte cultures between the third and fourth passages were used. Informed consent was obtained from all donors providing tissue samples, and ethical